Traders Buy UnitedHealth Group Incorporated (UNH) on Weakness
Traders purchased shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading hours on Monday. $230.31 million flowed into the stock on the tick-up and $83.78 million flowed out of the stock on the tick-down, for a money net flow of $146.53 million into the stock. Of all stocks tracked, UnitedHealth Group had the highest net in-flow for the day. UnitedHealth Group traded down ($1.76) for the day and closed at $196.30
Several analysts have recently issued reports on the company. Sanford C. Bernstein reiterated an “outperform” rating and issued a $210.00 price objective on shares of UnitedHealth Group in a research note on Tuesday. Cowen and Company reiterated an “outperform” rating and issued a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday. Morgan Stanley increased their price objective on UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a research note on Friday, August 18th. Three research analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $203.59.
The firm’s 50 day moving average price is $196.59 and its 200-day moving average price is $184.23. The firm has a market cap of $188.23 billion, a P/E ratio of 23.39 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.96 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.13%.
In related news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now owns 1,818,898 shares in the company, valued at $348,700,935.58. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the sale, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 76,174 shares of company stock worth $14,981,909. 0.89% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Honeywell International Inc. acquired a new stake in UnitedHealth Group during the first quarter worth about $35,262,000. Schwab Charles Investment Management Inc. raised its stake in UnitedHealth Group by 5.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after acquiring an additional 183,401 shares during the period. Suntrust Banks Inc. raised its stake in UnitedHealth Group by 8.5% during the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock worth $42,774,000 after acquiring an additional 20,541 shares during the period. Factory Mutual Insurance Co. raised its stake in UnitedHealth Group by 20.9% during the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after acquiring an additional 72,000 shares during the period. Finally, Shell Asset Management Co. raised its stake in UnitedHealth Group by 0.8% during the second quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock worth $29,156,000 after acquiring an additional 1,254 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/10/11/traders-buy-unitedhealth-group-incorporated-unh-on-weakness.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.